argenx (ARGX) · efgartigimod
Narrower window · A neutral label from comparing the two stated windows. It says nothing about the program’s results.
Before
Stated timing: second half of 2026
topline results expected in second half of 2026
EX-99.1 · filed · SEC filing
After
Stated timing: third quarter of 2026
Topline results from ALKIVIA study (myositis) expected in third quarter of 2026
SEC original · filed · SEC filing
Data as of . Both sentences are quoted from the SEC filings linked above and matched to them.
Source: ORION, orionbiotechai.com/changes/ARGX-efgartigimod-2026-05-07, data as of Oct 13, 2026
https://www.orionbiotechai.com/changes/ARGX-efgartigimod-2026-05-07
argenx (ARGX) pipeline and stated timing · Calendar · Companies A–Z